tiprankstipranks
Infant Bacterial Therapeutics AB (DE:9IB)
BERLIN:9IB
Germany Market

Infant Bacterial Therapeutics AB (9IB) Cash flow

Compare
4 Followers

Infant Bacterial Therapeutics AB Cash Flow

DE:9IB's free cash flow for Q4 2024 was kr-8.36M. For the 2024 fiscal year, DE:9IB's free cash flow was decreased by kr-15.42M and operating cash flow was kr-8.36M. See a summary of the company’s cash flow.
Cash Flow
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
kr -101.22Mkr -85.80Mkr -55.62Mkr -58.39Mkr -51.30M
Investing Cash Flow
kr -4.15Mkr -1.00Kkr 0.00kr 0.00kr 0.00
Financing Cash Flow
kr 96.52Mkr 1.88Mkr 91.00Kkr 1.76Mkr 0.00
End Cash Position
kr 329.06Mkr 335.84Mkr 386.75Mkr 423.44Mkr 495.19M
Free Cash Flow
kr -101.22Mkr -85.80Mkr -55.62Mkr -58.39Mkr -51.30M
Currency in SEK

Infant Bacterial Therapeutics AB Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis